- Shares of Xylem (XYL -11.3%) fall hard as the company says adjusted EPS decreased 26% Y/Y in Q2. Organic revenue growth came in at -3.4% for the period.
- Weakness in Europe "more than offset" strength in U.S. residential, commercial, and agricultural businesses.
- Outlook is "adjusted to reflect on-going market weakness." Management now sees FY13 EPS of $1.40-1.50 on revenue of $3.7B. Consensus is $1.82/ share on $3.87B in sales. (PR)
Xylem sinks as earnings, revenue, guidance come up short
Check out Seeking Alpha’s new Earnings Center »
From other sites
at Nasdaq.com (Thu, 10:53AM)
at Nasdaq.com (Feb 24, 2015)
at Nasdaq.com (Feb 12, 2015)
at Nasdaq.com (Jan 14, 2015)
at Benzinga.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs